Global Research Antibodies And Reagents Market Research Report 2018Posted by Bharat Book on February 27th, 2018 Bharat Book Bureau Provides the Trending Market Research Report on Global Research Antibodies And Reagents Market Opportunity Analysis And Industry Forecast 2018-2023 under Life Science category. The report provides information on industry overview, market size, latest developments, industry trends, Key players, global presence, and their future prospects. Research Antibodies and Reagents Market by Product (Reagents and Research Antibodies), by Technology (Western Blotting, Immunofluorescence, Immunosorbent Assays, Flow Cytometry, Immunohistochemistry, and Immunoprecipitation), by Application (Proteomics, Drug Discovery & Development, and Genomics), and by End User (Pharmaceutical & Biotechnology Industry, Academic & Research Institutes, and Contract Research Organizations)- Global Opportunity Analysis and Industry Forecasts To 2023 Research antibodies and reagents are used concurrently during an experimental research for the development of protein, gene, or antigen specific drugs and biomarkers for rapid detection and diagnosis of chronic diseases. Global research antibodies and reagents market is expected to reach USD 13,276.5 million by 2023, at a CAGR of 6.5% during the forecast period of 2018 to 2023. Request a free sample copy of Research Antibodies And Reagents Market Report @ Succeeding an extensive secondary and primary research on research antibodies & reagents and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Rising proteomics and genomics research studies, increasing funding for research activities, and growing industry-academia collaborations are majorly driving the global research antibodies and reagents market. However, high cost and time related to development of potential antibodies hinders the growth of this market to some extent. In addition, the report further gives an extensive outlook on various healthcare facilities served by the research antibodies and reagents. These industries include pharmaceutical and biotechnology industry, academic and research institutes, and contract research organizations. These end user segments further briefly talks about the trends impacting the growth of these markets and the benefits involved with the use of research antibodies and reagents in these verticals to improve overall efficiency and outcomes of the research experiments for drug discovery and development. An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographical analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, government & private investments, and regulatory scenario. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries. The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017). The key players in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck & Co., Inc.(U.S.), Thermo Fisher Scientific Inc.(U.S.), Amgen Inc.(U.S.), Sanofi (France), F. Hoffmann La-Roche Ltd (Switzerland), Rockland Immunochemicals Inc.(U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc.(U.S.), Eli Lilly and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc.(U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc.(U.S.), BioLegend, Inc.(U.S.), Abcam PLC (U.K.), and Cell Signaling Technology, Inc.(U.S.). Scope of the report Market by Product: • Research Antibodies Research Antibodies Market, by Type Research Antibodies Market, by Production Research Antibodies Market, by Source Research Antibodies Market, by Research Areas Market by Technology: Market by Application: Market by End User: Market by Geography • Europe • Asia-Pacific (APAC) • Latin America • Middle East & Africa Browse our full report with Table of Contents : About Bharat Book Bureau: Contact us at: Follow us on : Twitter, Facebook, LinkedIn, Google Plus Like it? Share it! More by this author |